Skip to main content
Clinical Trials/NCT01879566
NCT01879566
Withdrawn
Not Applicable

Effect of Catheter-based Radiofrequency Ablation Therapy of the Renal Sympathetic-Nerve System for Patient With Sleep Apnea Syndrome and Therapy Resistant Hypertension

University of Zurich1 site in 1 countryMay 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Therapy-resistant Hypertension and Sleep Apnea
Sponsor
University of Zurich
Locations
1
Primary Endpoint
Change in sympathetic nervous system activity (burst/min and burst/100 HB) before and after catheter-based radiofrequency ablation
Status
Withdrawn
Last Updated
8 years ago

Overview

Brief Summary

The aim of this prospective single-center study is to evaluate sympathetic nervous system directly measured by microneurography, 24-hour blood pressure, endothelial function, vascular compliance, quality of life and platelet adhesion in patients with sleep apnea syndrome (defined by a complaint of excessive daytime sleepiness, an Epworth sleepiness score>8[10], and an apnea/hypopnea index (AHI>15/h) before and after catheter-based radiofrequency ablation of renal nerve. If the selected patients are treated with CPAP, this therapy should be stable during the whole study time. Primary and secondary end-point will be measured before and 1, 3, 6 and 12 months after renal sympathetic denervation.

Registry
clinicaltrials.gov
Start Date
May 2013
End Date
July 2017
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Change in sympathetic nervous system activity (burst/min and burst/100 HB) before and after catheter-based radiofrequency ablation

Time Frame: 6 and 12 months

The primary objective of this study is to evaluate sympathetic nervous system activity in patients with sleep apnea syndrome before and 6 and 12 months after catheter-based radiofrequency ablation therapy of the renal sympathetic-nerve system

Secondary Outcomes

  • Change in 24-hour blood pressure (24 hour, day and night mean) before and after catheter-based renal denervation(1, 3, 6 12 months)
  • Change in renal function (creatinin plasma level and GFR CKD-EPI Formula) before and after catheter-based renal denervation(1, 3, 6, 12)
  • Change in 24-hour Holter and heart rate variability, echocardiogramm before and after catheter-based renal denervation(6 and 12 months)
  • Change in sleep quality, pulse-oximetry, AHI, quality of life and subjective sleepiness with the Epworth sleepiness score before after catheter-based renal denervation(1, 3, 6 and 12 months)
  • Change in vascular function and oxidative stress and inflammation parameters before and after catheter-based renal denervation(1, 3, 6, and 12 months)

Study Sites (1)

Loading locations...

Similar Trials